Frankfurt
07.01.26 | 18:12
0,139 Euro
+4,51 % +0,006
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| Fr | Vext Science Inc: Vext Science investor Nguyen sells 20,340 shares | 7 | Stockwatch | ||
| 11.12.25 | VEXT Science, Inc.: Vext Announces Voting Results of Annual General Meeting | 332 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 20.11.25 | VEXT Science, Inc.: Vext Reports Q3 2025 Financial Results | 933 | Newsfile | Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations... ► Artikel lesen | |
| 20.11.25 | Vext Science Inc: Vext Science has EBITDA of $2.31M (U.S.) in Q3 2025 | 4 | Stockwatch | ||
| 20.11.25 | Vext Science reports Q3 results | 4 | Seeking Alpha | ||
| 11.11.25 | Vext Science Inc: Vext Science to release Q3 2025 results Nov. 20 | 1 | Stockwatch | ||
| 11.11.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q3 2025 on November 20, 2025 | 330 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 17.09.25 | Vext Science Inc: Vext receives OK for Ohio dispensary ownership transfer | 1 | Stockwatch | ||
| 17.09.25 | VEXT Science, Inc.: Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer | 333 | Newsfile | Upon closing, expected by October 1, 2025, Portsmouth will become Vext's fifth fully consolidated dispensary in Ohio. The Company expects to bring additional locations online through late 2025 and... ► Artikel lesen | |
| 20.08.25 | Vext Science reports Q2 results | 6 | Seeking Alpha | ||
| 20.08.25 | VEXT Science, Inc.: Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin | 505 | Newsfile | Record financial performance, with growth in revenue, adjusted EBITDA, and operating cash flow driven by strong Ohio momentum and disciplined operations in Arizona.Revenue of $13.4 million, up 59%... ► Artikel lesen | |
| 11.08.25 | Vext Science Inc: Vext Science to issue, host call for Q2 results Aug. 20 | 1 | Stockwatch | ||
| 11.08.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q2 2025 on August 20, 2025 | 311 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
| 24.06.25 | VEXT Science, Inc.: Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield | 345 | Newsfile | Secures a provisional license for sixth Ohio dispensary in Fairfield, with operations expected to begin in Q4 2025, subject to regulatory approvals.Demonstrates Vext's strategic approach to retail... ► Artikel lesen | |
| 16.06.25 | VEXT Science, Inc.: Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market | 345 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 16, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 05.06.25 | VEXT Science, Inc.: Vext Announces Change of Auditor | 582 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 21.05.25 | VEXT Science, Inc.: Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue | 449 | Newsfile | Revenue grew 38% to $11.6 million compared to $8.4 million in Q1 2024, and up 13% sequentially from $10.2 million in Q4 2024, driven by growth in Ohio.Q1 2025 operating cash flow reached $3.1 million... ► Artikel lesen | |
| 13.05.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q1 2025 on May 21, 2025 | 398 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 13, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 04.04.25 | VEXT Science, Inc.: Vext Strengthens Balance Sheet and Sharpens Focus on Core Markets with Strategic Sale of Kentucky Medical Processing License | 505 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertically integrated operations... ► Artikel lesen | |
| 03.04.25 | VEXT Science, Inc.: Vext Completes Ohio Expansion Transaction, Expanding Ohio Retail Presence to Four Dispensaries | 481 | Newsfile | Vext now operates four retail dispensaries in Ohio's limited license market and remains on track to reach the state license cap of eight (8) total dispensaries, with new locations expected to open... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,645 | +0,28 % | Cannabis-Aktien im Abverkauf: Böses Omen für 2026? Anleger in Alarmstimmung bei Tilray, Canopy, Aurora & Co. | © Foto: adobe.stock.comMit dem Börsenjahr 2025 geht für den Cannabis-Sektor einmal mehr ein Jahr voller Herausforderungen zu Ende. Das Vertrauen von Anlegern und Investoren ist noch nicht zurück. Der... ► Artikel lesen | |
| CANOPY GROWTH | 1,032 | +0,78 % | Nach der Trump-Unterschrift: Auch 2026 kein Ende der Leidenszeit? Canopy, Aurora, Tilray mit Kursbeben | © Foto: adobe.stock.comDie Spekulationen schossen ins Kraut, dass Trump eine Executive Order auf den Weg bringen würde, um den festgefahrenen Rescheduling-Prozess zu beschleunigen. Der Cannabis-Sektor... ► Artikel lesen | |
| TILRAY BRANDS | 7,729 | +0,47 % | Tilray Brands Q2 preview: Bottom line weakness to persist but reclassification offers hope | ||
| INNOCAN PHARMA | 4,840 | -1,22 % | Innocan Pharma Corporation plant Listing an der NYSE American Stock Exchange mit gleichzeitigem Emissionsangebot | Herzliya, Israel und Calgary, AB - 2. Januar 2026 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTCQB: INNPF) (das "Unternehmen" oder "Innocan"), ein
pharmazeutisches Technologieunternehmen... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,338 | +2,01 % | Cronos Group Inc.: Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company | Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027 Up-front consideration represents approximately 1.4x CanAdelaar... ► Artikel lesen | |
| SYNBIOTIC | 3,200 | +1,43 % | Original-Research: SYNBIOTIC SE (von NuWays AG): BUY | Original-Research: SYNBIOTIC SE - from NuWays AG
19.12.2025 / 09:26 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for... ► Artikel lesen | |
| DIGICANN VENTURES | 0,001 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,380 | -4,17 % | Organigram Global Inc: Organigram increases Phylos loan by $3-million (U.S.) | ||
| GREEN THUMB INDUSTRIES | 7,100 | +1,36 % | Tilray, Green Thumb & Co: Trump lockert Cannabis-Regeln | US-Präsident Donald Trump hat mit einer neuen Executive Order einen tiefgreifenden Kurswechsel in der amerikanischen Cannabispolitik angestoßen. Künftig soll Marihuana nicht mehr in die strengste Kategorie... ► Artikel lesen | |
| SNDL | 1,421 | +0,21 % | 1CM Inc.: SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased... ► Artikel lesen | |
| CRESCO LABS | 1,034 | +0,10 % | Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry | Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump's action to... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,117 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 22.10.2025 | The following instruments on XETRA do have their first trading 22.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 22.10.2025
Aktien
1 KYG8827C1006 Malibu Life Holdings... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 6,450 | +0,78 % | Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS) | TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 1,360 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly Food Group's Multi-Unit Franchisee for Heal Wellness QSR in Alberta Secures 11th Real-Estate Location | Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands... ► Artikel lesen |
VEXT SCIENCE INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell +4,51 % bei einem Aktienkurs von 0,139 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.